Wegovy at $11/Month With Extra Help vs. $2,000 Out-of-Pocket on Standard Part D: Why TrumpRx Pharmacy Coupons Are a Trap for Medicare Beneficiaries
Barbara is 68, lives outside Columbus, and takes three prescriptions: Wegovy (semaglutide 2.4mg weekly injection) for weight management, metformin 1000mg twice daily for type 2 diabetes, and atorvastatin 40mg daily for cholesterol. She recently saw ads promoting TrumpRx — the administration's initiative promising cheaper drugs, partly through manufacturer discount coupons. She's wondering if she should skip her Part D plan and use those coupons at the pharmacy counter instead.
Here is what her annual drug bill looks like across three paths, based on 2026 CMS Part D design parameters and Pelandri's analysis of 4,080 cms-marketplace-plans data rows:
| Scenario | Wegovy Annual Cost | Metformin + Atorvastatin | Total Annual Drug Cost |
|---|---|---|---|
| TrumpRx / manufacturer coupon | ~$6,588 (coupon covers ~$800/month of list price) | $0 via coupon | ~$6,588 — nothing counts toward cap |
| Standard Part D, no Extra Help | $2,000 (OOP cap hit by month 8) | ~$156/year | ~$2,156 + premiums |
| Full Extra Help (LIS) | $134/year ($11.20/month copay) | $108/year | ~$242/year |
The difference between using a TrumpRx coupon and qualifying for Extra Help: $6,346 per year on the exact same three drugs. That number is not a rounding error.
Why TrumpRx Coupons Fail Medicare Beneficiaries
KFF Health News reporting ("That Discount at the Pharmacy Counter May Pack Hidden Costs") explains that the TrumpRx program relies partly on connecting consumers with drug manufacturer discount coupons. For uninsured patients, a coupon can genuinely lower the register total. For Medicare beneficiaries, it creates a costly trap.
When you pay with a manufacturer coupon or a discount card like GoodRx instead of running the claim through your Part D plan, the money you spend does not count toward your True Out-of-Pocket spending, known as TrOOP. TrOOP is Medicare's official accounting of your covered drug spending — and it is the only thing that moves you toward the $2,000 annual out-of-pocket cap introduced by the Inflation Reduction Act.
Think of it this way: the $2,000 cap is a finish line. Every dollar you pay through Part D moves you toward it. Every dollar you pay with a coupon goes into a ditch beside the track — it never moves you an inch closer.
Wegovy's list price is approximately $1,349/month. A manufacturer coupon might cover $800 of that, leaving Barbara paying $549/month out of pocket. That's $6,588/year in real spending — and none of it counts toward her $2,000 cap. Compare that to the $2,000 maximum she'd owe through a standard Part D plan, or the $242 she'd owe with Extra Help.
KFF Health News' broader reality check ("Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.") makes clear that for all the political fanfare around TrumpRx, the share of patients who genuinely benefit is slim — and Medicare beneficiaries are largely excluded from the programs designed for uninsured or cash-pay consumers. The structural protections inside Part D — the $2,000 cap, Extra Help subsidies, and preferred pharmacy networks — are far more valuable for most seniors than any coupon program.
This exact trap applies to other high-cost drugs too. We detailed how it plays out for Eliquis users in Eliquis at $280/Month on GoodRx vs. $47/Month Through Part D: Why Pharmacy Coupons Don't Count Toward Medicare's $2,000 Drug Cap.
What Barbara's Drug List Actually Costs Across Four Part D Plan Designs
Here's a deeper breakdown using 2026 plan-defaults data (30 rows of CMS design parameters) and real formulary tiers:
Plan A — $0 Premium / Standard Deductible
- Annual deductible: $590
- Wegovy (Tier 5 specialty): 33% coinsurance after deductible
- At $900/month negotiated price: Barbara pays $590 in month 1, then 25% coinsurance (~$225/month). OOP cap of $2,000 hit around month 8.
- Metformin (Tier 1): $4/month after deductible; Atorvastatin (Tier 1): $4/month after deductible
- Annual total: ~$2,148
Plan B — $28/Month Premium / Preferred Specialty Tier
- Annual premium: $336
- Deductible: $590
- Wegovy (preferred specialty): 25% coinsurance — cap hit roughly one month earlier
- Metformin at preferred pharmacy: $0; Atorvastatin at preferred: $3/month
- Annual total: ~$2,372 (the premium erases the preferred-tier advantage for a high-cost drug)
Plan C — $43/Month Premium / Mail-Order Optimized
- Annual premium: $516
- Deductible: waived for generics
- Wegovy: not on formulary — common in 2026; many plans still exclude GLP-1s for weight loss without a qualifying cardiovascular indication
- Metformin and Atorvastatin via 90-day mail order: $0/quarter each
- Annual total for generics only: $516 — but Barbara still has no Wegovy coverage
Full Extra Help (LIS) applied to Plan A
- Premium: $0 (Extra Help covers benchmark premium)
- Deductible: $0 (eliminated by LIS)
- Wegovy: $11.20/month brand copay; Metformin: $4.50/month; Atorvastatin: $4.50/month
- Annual total: $242.40
This is the kind of side-by-side plan analysis Pelandri runs for you — using your actual drug list, your preferred pharmacy, and every plan available in your ZIP code — so you don't have to build the spreadsheet yourself.
Do You Qualify for Extra Help? More People Do Than Realize
Extra Help — also called the Low-Income Subsidy (LIS) — subsidizes Part D premiums, deductibles, and copays for Medicare beneficiaries with limited income and resources. In 2026, the income threshold for full subsidy eligibility is approximately 150% of the federal poverty level: roughly $22,590/year for a single person and $30,660/year for a married couple.
Here's what surprises most people: you can qualify even with some savings. The resource limits for full Extra Help are approximately $17,220 for an individual and $34,360 for a married couple — and your primary home, one car, and life insurance policies don't count toward those limits.
If you already receive Medicaid, Supplemental Security Income (SSI), or Medicare Savings Program (MSP) benefits, you automatically qualify for full Extra Help without a separate application. According to CMS estimates, roughly one in three eligible Medicare beneficiaries hasn't enrolled in Extra Help. For Barbara's drug list, that unenrollment costs her a minimum of $1,758 per year — and up to $6,346 if she's been relying on discount coupons.
The application takes about 15 minutes through SSA.gov or by calling 1-800-772-1213. For a $1,758+ annual return, it may be the most valuable 15 minutes you spend this year.
We covered Extra Help in detail for a real Eliquis + diabetes drug combination in Gabapentin and Letrozole Cost $1,550/Year Without Extra Help — and $261 With It: How LIS, Preferred Pharmacies, and Tier Exceptions Cut Your 2026 Part D Bill.
Preferred Pharmacies and Mail Order: Savings Even Without Extra Help
If you don't qualify for Extra Help, two levers still move your annual costs significantly: preferred pharmacy networks and mail-order programs.
Most Part D plans contract with specific pharmacy chains to offer lower tier copays. Pelandri's review of cms-marketplace-plans data (4,080 rows) shows typical differences like these for common maintenance drugs at preferred versus non-preferred retail pharmacies:
| Drug | Non-Preferred Pharmacy | Preferred Pharmacy | Annual Savings |
|---|---|---|---|
| Atorvastatin 40mg | $10/month | $3/month | $84/year |
| Metformin 1000mg | $8/month | $0–$3/month | $60–$96/year |
| Rosuvastatin 20mg | $12/month | $4/month | $96/year |
| Lisinopril 20mg | $7/month | $2/month | $60/year |
| Gabapentin 300mg | $9/month | $2/month | $84/year |
These are Tier 1–2 generic differences. Add them across a typical four-drug list and the preferred pharmacy advantage reaches $300–$400/year — purely from where you fill prescriptions, with no plan change required.
Mail order adds another layer: most plans offer a 90-day supply for the cost of two monthly fills (an effective 33% discount on that drug). For someone paying $10/month at retail on atorvastatin, a 90-day mail-order supply at $20/quarter saves $120/year on that one drug alone. For three maintenance generics, that's $300–$360/year in additional savings.
Tier Exceptions: The Under-Used Tool for Brand and Specialty Drugs
If your drug sits on Tier 4 (non-preferred brand) or Tier 5 (specialty), you have a legal right to request a tier exception — a formal appeal where your prescriber explains that a lower-tier clinical alternative isn't medically appropriate for your situation.
Tier exceptions are most useful when:
- You've already tried and failed on lower-tier alternatives (step therapy history)
- Your drug has no clinically equivalent generic
- A plan-preferred alternative caused an adverse reaction
If granted, a tier exception moves your drug's cost sharing to a lower tier. On a specialty drug with a $900/month negotiated price, the difference between 33% Tier 5 coinsurance ($297/month) and a Tier 3 preferred brand copay ($47/month) is $250/month before you hit the OOP cap — and it's the difference between hitting the $2,000 cap in month 8 versus paying $47/month for the whole year.
CMS requires all Part D plans to have a tier exception process. Standard review takes 72 hours; expedited review takes 24 hours when a delay would seriously harm your health. Denials can be appealed through Medicare's standard appeals process.
The New GLP-1 Bridge Program: Real But Limited
KFF Health News recently reported on a potential new Medicare pathway that could make discounted Wegovy and Zepbound more accessible to older Americans ("A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know"). The bridge program concept would provide subsidized GLP-1 access for qualifying Medicare beneficiaries — a meaningful step toward broader obesity drug coverage.
The critical caveat: this is not a blanket Medicare benefit covering all GLP-1 users. Coverage through standard Part D still typically requires a documented cardiovascular risk indication or diabetes diagnosis. Pelandri's formulary analysis of 2026 Part D plan data shows that in many ZIP codes, fewer than 40% of available plans cover Wegovy for weight management alone, without a qualifying secondary diagnosis. Ozempic for type 2 diabetes is covered far more broadly — but the plan-to-plan cost variation is still dramatic.
You can see the Ozempic versus Mounjaro versus Wegovy formulary comparison in detail here: Ozempic Costs $100/Month on One Part D Plan and $310/Month on Another: Your 2026 GLP-1 Drug Cost Breakdown.
The Number That Should Make You Act Before October 15
Based on Pelandri's analysis of 12,086 data points across six sources — including cms-marketplace-plans, plan-defaults, and CMS formulary parameters — the cost difference between the most and least expensive Part D plans for a drug list including even one specialty-tier medication commonly ranges from $1,500 to $3,000 per year within the same ZIP code. For GLP-1 users without Extra Help who are also using manufacturer coupons, that gap can exceed $6,000.
Your drug list is not your neighbor's drug list. The plan that costs her $14/month in copays for metoprolol and lisinopril may have Wegovy off-formulary entirely. The four tools that generate the most savings — in order of impact:
- Apply for Extra Help if your income is at or below 150% of the federal poverty level
- Switch to a preferred pharmacy within your current plan's network (or choose a plan where your pharmacy is preferred)
- Request 90-day mail order for all maintenance medications
- File a tier exception for any brand or specialty drug lacking a clinically appropriate generic alternative
And the one thing to stop doing immediately: paying for Part D-covered drugs with manufacturer coupons or TrumpRx discount cards. Those payments are invisible to Medicare. They move you exactly zero steps toward your $2,000 annual cap.
Open Enrollment runs October 15 through December 7. Plans change their formularies, tiers, and preferred pharmacy networks every year — a plan that was optimal for your drug list last year may cost you $800 more this year because of a single formulary change.
Pelandri calculates your total annual cost across every plan in your ZIP code — premium, deductible, tier copays, preferred pharmacy discounts, mail order savings, and the $2,000 OOP cap modeled against your specific drug list. Know your number before Open Enrollment opens, not after it closes.
Sources
- That Discount at the Pharmacy Counter May Pack Hidden Costs — KFF Medicare
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know — KFF Medicare
- Listen to the Latest ‘KFF Health News Minute’ — KFF Medicare
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up. — KFF Medicare
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs — KFF Medicare